The antidepressant drug sertraline is a novel inhibitor of yeast Pah1 and human lipin 1 phosphatidic acid phosphatases
Journal of Lipid Research · 2025
DOI: 10.1016/j.jlr.2024.100711 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Lipid Research, 2025. Verfasst von Geordan J Stukey und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science, Rutgers University, New Brunswick, NJ, USA; Rutgers Center for Lipid Research, Rutgers University, New Brunswick, NJ, USA. Hauptthemen laut MEDLINE: Phosphatidate Phosphatase, Sertraline, Saccharomyces cerevisiae, Saccharomyces cerevisiae Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Phosphatidic acid phosphatase (PAP) is an evolutionarily conserved eukaryotic enzyme that catalyzes the Mg2+-dependent dephosphorylation of phosphatidic acid to produce diacylglycerol. The product and substrate of PAP are key intermediates in the synthesis of triacylglycerol and membrane phospholipids. PAP activity is associated with lipid-based cellular defects indicating the enzyme is an important target for regulation. We identified that the antidepressant sertraline is a novel inhibitor of PAP. Using Saccharomyces cerevisiae Pah1 as a model PAP, sertraline inhibited the activity by a noncompetitive mechanism. Sertraline also inhibited the PAP activity of human lipin 1 (α, β, and γ), an orthologue of Pah1. The inhibitor constants of sertraline for the S. cerevisiae and human PAP enzymes were 7-fold and ∼2-fold, respectively, lower than those of propranolol, a commonly used PAP inhibitor. Consistent with the inhibitory mechanism of sertraline and propranolol, molecular docking of the inhibitors predicts that they interact with non-catalytic residues in the haloacid dehalogenase-like catalytic domain of Pah1. The Pah1-CC (catalytic core) variant, which lacks regulatory sequences, was inhibited by both drugs in accordance with molecular docking data. That Pah1 is a physiological target of sertraline in S. cerevisiae is supported by the observations that the overexpression of PAH1 rescued the sertraline-mediated inhibition of pah1Δ mutant cell growth, the lethal effect of overexpressing Pah1-CC was rescued by sertraline supplementation, and that a sublethal dose of the drug resulted in a 2-fold decrease in TAG content.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food Science, Rutgers University, New Brunswick, NJ, USA; Rutgers Center for Lipid Research, Rutgers University, New Brunswick, NJ, USA.
- Department of Biology, Texas A&M University, College Station, TX, USA.
- Rutgers Center for Lipid Research, Rutgers University, New Brunswick, NJ, USA; Department of Nutritional Sciences, Rutgers University, New Brunswick, NJ, USA.
- Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Graduate Group in Biochemistry & Molecular Biophysics, Perelman School of Medicine, University o…
- Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Biochemistry & Biophysics, Perelman School of Medicine, University of Pennsylvania…
- Department of Food Science, Rutgers University, New Brunswick, NJ, USA; Rutgers Center for Lipid Research, Rutgers University, New Brunswick, NJ, USA. Electronic address: gcarman@rutgers.edu.
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- NIDDK NIH HHS
- NIAID NIH HHS
- National Institute of General Medical Sciences
- U.S. Public Health Service
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Stukey, G. J., Breuer, M. R., Burchat, N., Jog, R., Schultz, K., Han, G. S., Sachs, M. S., Sampath, H., Marmorstein, R., & Carman, G. M. (2025). The antidepressant drug sertraline is a novel inhibitor of yeast Pah1 and human lipin 1 phosphatidic acid phosphatases. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2024.100711
Vancouver
Stukey GJ, Breuer MR, Burchat N, Jog R, Schultz K, Han GS, et al. The antidepressant drug sertraline is a novel inhibitor of yeast Pah1 and human lipin 1 phosphatidic acid phosphatases. Journal of Lipid Research. 2025. doi:10.1016/j.jlr.2024.100711
BibTeX
@article{Stukey2025,
author = {Stukey, Geordan J and Breuer, Matthew R and Burchat, Natalie and Jog, Ruta and Schultz, Kollin and Han, Gil-Soo and Sachs, Matthew S and Sampath, Harini and Marmorstein, Ronen and Carman, George M},
title = {The antidepressant drug sertraline is a novel inhibitor of yeast Pah1 and human lipin 1 phosphatidic acid phosphatases},
journal = {Journal of Lipid Research},
year = {2025},
doi = {10.1016/j.jlr.2024.100711}
}
EUVIMED